InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Douglas Kerr, Chief Medical Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 8 open-market SEC Form 4 transactions: 0 purchases worth $0 and 8 sales worth $169K, reported from Mar 5, 25 to Jun 16, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 26 | DYNDyne Therapeutics, Inc. | SELL | 887 | $18.33 | $16K |
| May 13, 26 | DYNDyne Therapeutics, Inc. | SELL | 1.6K | $18.36 | $29K |
| Mar 5, 26 | DYNDyne Therapeutics, Inc. | SELL | 904 | $14.90 | $13K |
| Dec 5, 25 | DYNDyne Therapeutics, Inc. | SELL | 880 | $20.72 | $18K |
| Sep 5, 25 | DYNDyne Therapeutics, Inc. | SELL | 873 | $13.41 | $12K |
| Sep 4, 25 | DYNDyne Therapeutics, Inc. | SELL | 3.6K | $13.27 | $47K |
| Jun 5, 25 | DYNDyne Therapeutics, Inc. | SELL | 1.3K | $13.35 | $18K |
| Mar 5, 25 | DYNDyne Therapeutics, Inc. | SELL | 1.3K | $11.83 | $16K |